Mutant huntingtin impairs PNKP and ATXN3, disrupting DNA repair and transcription

被引:81
|
作者
Gao, Rui [1 ]
Chakraborty, Anirban [2 ]
Geater, Charlene [3 ,4 ]
Pradhan, Subrata [1 ]
Gordon, Kara L. [5 ]
Snowden, Jeffrey [1 ]
Yuan, Subo [6 ]
Dickey, Audrey S. [5 ]
Choudhary, Sanjeev [7 ]
Ashizawa, Tetsuo [8 ]
Ellerby, Lisa M. [9 ]
La Spada, Albert R. [5 ]
Thompson, Leslie M. [3 ,4 ,10 ]
Hazra, Tapas K. [2 ]
Sarkar, Partha S. [1 ,6 ]
机构
[1] Univ Texas Med Branch, Dept Neurol, Galveston, TX 77555 USA
[2] Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA
[3] Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA 92717 USA
[4] Univ Calif Irvine, Sue & Bill Gross Stem Cell Ctr, Irvine, CA USA
[5] Duke Univ, Sch Med, Dept Neurol, Durham, NC USA
[6] Univ Texas Med Branch, Dept Neurosci Cell Biol & Anat, Galveston, TX 77555 USA
[7] Sam Houston State Univ, Dept Biochem Cell Biol & Genet, Huntsville, TX 77340 USA
[8] Houston Methodist Res Inst, Dept Neurol, Houston, TX USA
[9] Buck Inst Res Aging, Novato, CA USA
[10] Univ Calif Irvine, Dept Neurobiol & Behav, Inst Memory Impairments & Neurol Disorders, Irvine, CA USA
来源
ELIFE | 2019年 / 8卷
关键词
CREB-BINDING PROTEIN; MEDIATED TRANSCRIPTION; CELL-DEATH; DISEASE; DAMAGE; GENE; ATAXIN-3; EXPRESSION; MODEL; CBP;
D O I
10.7554/eLife.42988
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
How huntingtin (HTT) triggers neurotoxicity in Huntington's disease (HD) remains unclear. We report that HTT forms a transcription-coupled DNA repair (TCR) complex with RNA polymerase II subunit A (POLR2A), ataxin-3, the DNA repair enzyme polynucleotide-kinase-3'-phosphatase (PNKP), and cyclic AMP-response element-binding (CREB) protein (CBP). This complex senses and facilitates DNA damage repair during transcriptional elongation, but its functional integrity is impaired by mutant HTT. Abrogated PNKP activity results in persistent DNA break accumulation, preferentially in actively transcribed genes, and aberrant activation of DNA damage-response ataxia telangiectasia-mutated (ATM) signaling in HD transgenic mouse and cell models. A concomitant decrease in Ataxin-3 activity facilitates CBP ubiquitination and degradation, adversely impacting transcription and DNA repair. Increasing PNKP activity in mutant cells improves genome integrity and cell survival. These findings suggest a potential molecular mechanism of how mutant HTT activates DNA damage-response pro-degenerative pathways and impairs transcription, triggering neurotoxicity and functional decline in HD.
引用
收藏
页数:31
相关论文
共 50 条
  • [21] The (CAG)n tract of Machado-Joseph Disease gene (ATXN3): a comparison between DNA and mRNA in patients and controls
    Bettencourt, Conceicao
    Santos, Cristina
    Montiel, Rafael
    Kay, Teresa
    Vasconcelos, Joao
    Maciel, Patricia
    Lima, Manuela
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2010, 18 (05) : 621 - 623
  • [22] Allele-Specific Silencing of Mutant ATXN3 Mitigates Motor Deficits and Neuropathology in a Severely Impaired Mouse Model of Spinocerebellar Ataxia Type 3 (SCA3)
    Silva, Ana Carolina
    Henriques, Carina
    Lobo, Diana
    Fernandes, Ana Rita
    Lopes, Miguel
    Pereira, Dina
    Duarte, Sonia
    Baganha, Rafael
    Lopes, Sara
    Santana, Magda
    Nobre, Rui Jorge
    de Almeida, Luis Pereira
    MOLECULAR THERAPY, 2024, 32 (04) : 485 - 485
  • [23] Molecular characterization of mutant alleles of the DNA repair basal transcription factor haywire/ERCC3 in Drosophila
    Mounkes, LC
    Fuller, MT
    GENETICS, 1999, 152 (01) : 291 - 297
  • [24] CRISPR-Cas9-Mediated Pre-Transcriptional Silencing of Mutant ATXN3 Decreases Motor Impairments of an In Vivo Machado-Joseph Disease Model
    Matos, Carlos
    Pena, Frederico
    Conceicao, Andre
    Lopes, Sara
    Duarte, Sonia
    Miranda, Catarina
    de Almeida, Luis Pereira
    MOLECULAR THERAPY, 2019, 27 (04) : 120 - 121
  • [25] Age-dependent somatic expansion of the ATXN3 CAG repeat in the blood and buccal swab DNA of individuals with spinocerebellar ataxia type 3/Machado-Joseph disease
    Sidky, Ahmed M.
    Melo, Ana Rosa Vieira
    Kay, Teresa T.
    Raposo, Mafalda
    Lima, Manuela
    Monckton, Darren G.
    HUMAN GENETICS, 2024, 143 (11) : 1363 - 1378
  • [26] Allele-specific silencing of mutant ATXN3 rescues motor deficits and neuropathology in a severely impaired mouse model of spinocerebellar ataxia type 3 (SCA3) upon intra-cisterna magna administration
    Silva, A. C.
    Henriques, C.
    Lobo, D. D.
    Fernandes, A. R.
    Lopes, M.
    Pereira, D.
    Duarte, S. P.
    Baganha, R.
    Lopes, S. M.
    Santana, M.
    Nobre, R. J.
    Pereira de Almeida, L.
    HUMAN GENE THERAPY, 2024, 35 (3-4) : A180 - A180
  • [27] Interaction of estrogen receptor α with 3-methyladenine DNA glycosylase modulates transcription and DNA repair
    Likhite, VS
    Cass, EI
    Anderson, SD
    Yates, JR
    Nardulli, AM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (16) : 16875 - 16882
  • [28] A miRNA-based gene therapy approach to knock-down mutant ATXN3: Alleviation of Machado-Joseph disease phenotype in two mouse models upon two routes of administration
    Nobre, Rui Jorge
    Saraiva, Joana
    Fusco, Clelia
    Paixao, Susana
    Santana, Magda
    Miranda, Catarina
    Petrella, Lorena
    Sereno, Jose
    Castelhano, Joao
    Castelo-Branco, Miguel
    Sena-Esteves, Miguel
    Almeida, Luis
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2019, 49 : 88 - 89
  • [29] AZD1390 radio-sensitizes p53-mutant GBM via disrupting homology directed DNA repair
    Gupta, Shiv K.
    Chen, Jiajia
    Laverty, Daniel J.
    Talele, Surabhi
    Carlson, Brett L.
    Tuma, Ann C. Mladek
    Burgenske, Danielle
    Kitange, Gaspar J.
    Hamerlik, Petra
    Nagel, Zachary D.
    Durant, Stephen T.
    Elmquist, William F.
    Sarkaria, Jann N.
    CANCER RESEARCH, 2022, 82 (12)
  • [30] A 3'->5'XPB helicase defect in repair/transcription factor TFIIH of xeroderma pigmentosum group B affects both DNA repair and transcription
    Hwang, JR
    Moncollin, V
    Vermeulen, W
    Seroz, T
    vanVuuren, H
    Hoeijmakers, JHJ
    Egly, JM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (27) : 15898 - 15904